🇺🇸 FDA
Patent

US 9394545

Methods and compositions for regulation of transgene expression

granted A61PA61P1/16A61P11/00

Quick answer

US patent 9394545 (Methods and compositions for regulation of transgene expression) held by Sangamo Biosciences, Inc. expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/16, A61P11/00, A61P17/00, A61P3/00